Objective: To describe a cost-effectiveness analysis of 10- or 13-valent pneumococcal conjugate vaccine (PCV10 or 13) introduction in Paraguay compared to no vaccination.
Methods: The integrated TRIVAC vaccine cost-effectiveness model (version 2.0) jointly developed by the Pan American Health Organization's ProVac Initiative and the London School of Hygiene & Tropical Medicine was applied from the government and societal perspectives to estimate the cost-effectiveness (CE) of PCV introduction during 2010 and 2011.
Purpose: To determine MRSA carriage rates and genetic relationships of S. aureus strains in children attending day care centres in 14 cities from three geographic regions in Mexico.
Materials And Methods: Cross-Sectional Study performed in apparently healthy children aged from 6 mo to 6 yr attending day care centres (DCCs).
Unlabelled: Abstract.
Background: Growing antibiotic resistance demands the constant reassessment of antimicrobial efficacy, particularly in countries with wide antibiotic abuse, where higher resistance prevalence is often found. Knowledge of resistance trends is particularly important when prescribing antibiotics empirically, as is usually the case for urinary tract infections (UTIs).